Business Practice

Amgen accuses Sandoz of snubbing its advances in a complex biosimilar dispute

The 2014 Access to Medicine index shows progress – but companies remain “conservative”

The Ebola media frenzy has reminded the public how selfish our industry is. But, somehow, that doesn’t sound quite right...

Organizations all over the globe are taking action against drug resistance.

Patients and physicians are tweeting, snapchatting, pinning and posting about healthcare, – some are making the leap into the digital world.

In a world of regulatory rigor and complex supply chains, product recalls are becoming increasingly challenging.

Hiring gifted new employees is tough enough, but how do you keep them within your organization once you’ve got them?

Mysterious cyber attackers are hitting pharma manufacturing systems

New Alzheimer’s treatment gets $500 million collaborative boost

Opportunistic investors surf the wave of experimental treatments